Abstract 442P
Background
The number of permanent colostomies performed for rectal cancer is decreasing as trans-anal excision has become the first-choice surgical approach. However, the types of support required for patients who undergo permanent colostomies according to their courses are not elucidated. This study aims to identify the types of support needed by elderly permanent colostomy patients by the postoperative months and investigated how these affected their quality of life.
Methods
This study was performed by a hypothesis testing approach using an anonymous self-administered questionnaire, which were left with the participants, and 335 members of A Ostomy Association were recruited to participate. The questionnaire had three components: 11 original items about care needed by individuals with colostomies, the Ostomate QOL Survey and the SF-12v2. Basic respondent characteristics were totaled by simple tabulation, and correlation and multiple regression analyses were performed to investigate how the number of postoperative months affected the support that the individuals with permanent colostomies wished for, and how the support they wished for affected QOL. The survey period was September 2017. This study was approved by the research ethics committee of the institution.
Results
Data from 137 participants of the mean age of 76.5 years were included in the analysis. The analysis on how support individuals felt needed with permanent colostomies affected their QOL resulted in significant correlations between “Factors related to daily life” , “Physical condition” (β=-.294, p=.011), “Activity” (β=-.267, p=.011) and “Mental and emotional condition” (β=-.410, p=.000). The multiple regression analysis on the support that individuals with permanent colostomies wanted and health-related QOL resulted in significant associations between “Factors related to daily life” and “Roles in daily life ((β=-.285, p=.014) ,(β=-.363, p=.001).
Conclusions
This study suggested that there were differences in the support that elderly with permanent colostomies wanted depending on the number of months or years passed since their colostomy surgery. Furthermore, it showed that the more they wished for care related to their daily life and health-related QOL.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The author.
Funding
JAPS Grant-in-Aid for Scientific Research(B):25293443.
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
27P - The prognostic value of neutrophil to lymphocyte ratio (NLR) and 18F-FDG PET SUV in breast cancer patients underwent neoadjuvant chemotherapy
Presenter: Soong June Bae
Session: Poster display session
Resources:
Abstract
28P - Accuracy of core biopsy in predicting pathologic complete response in the breast in patients with complete/near complete clinical and radiological response (Complete Responders in the Breast – CRBr): A feasibility study
Presenter: Nisha Hariharan
Session: Poster display session
Resources:
Abstract
29P - Tumour response to neoadjuvant chemotherapy in breast cancer: Routine pathologic markers improve the predictive power of a cell-loss metric based on release of thymidine kinase 1 into blood
Presenter: Bernhard Tribukait
Session: Poster display session
Resources:
Abstract
30P - Comparison of metabolic changes between neoadjuvant chemotherapy and neoadjuvant endocrine therapy in premenopausal women with ER positive, HER2 negative breast cancer
Presenter: Ho-hyun Ryu
Session: Poster display session
Resources:
Abstract
31P - Circulating miR-155 as a potential therapeutic monitoring marker in breast cancer
Presenter: Sumadi Lukman Anwar
Session: Poster display session
Resources:
Abstract
32P - Profile of breast cancer epidemiology in Sanglah General Hospital, Denpasar, Bali from 2012 to 2019
Presenter: Citra Aryanti
Session: Poster display session
Resources:
Abstract
33P - Contrast enhanced chest CT in patients with breast cancer: Comprehensive imaging analysis and correlation with biological markers
Presenter: Bo Hwa Choi
Session: Poster display session
Resources:
Abstract
34P - Verification of metabolic regulatory mechanisms in androgen receptor-positive triple negative breast cancer
Presenter: Yuka Asano
Session: Poster display session
Resources:
Abstract
35TiP - Ribociclib plus goserelin with hormonal therapy versus physician choice chemotherapy in pre-/perimenopausal patients with HR+, HER2– inoperable locally advanced breast cancer (ABC): RIGHT choice study
Presenter: Yen-Shen Lu
Session: Poster display session
Resources:
Abstract
36TiP - A prospective study to assess response to neoadjuvant hormonal therapy in postmenopausal women with hormone-receptor positive breast cancer at a regional cancer centre in South India
Presenter: Shina Goyal
Session: Poster display session
Resources:
Abstract